InvestorsHub Logo
Followers 834
Posts 120214
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 45743

Tuesday, 12/12/2017 3:07:05 PM

Tuesday, December 12, 2017 3:07:05 PM

Post# of 108192
Re: ADXS NEO /ADRO/Neon/Gritstone

From ADRO’s CC today: They plan to announce pLADD (neoantigen vaccine using listeria vector) proof-of-concept immunogenicity data after treating a "small double digit" number of patients in the phase-1 trial in progress in non-MSI CRC patients.

ADRO considers two private companies—Neon Therapeutics (http://neontherapeutics.com/about-us/ ) and Gritstone Oncology (https://gritstoneoncology.com/ ) to be their main competitors in the neoantigen-vaccine arena.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News